The therapeutic potential of mTOR inhibitors in breast cancer-Reference-Cited by-同舟云学术

The therapeutic potential of mTOR inhibitors in breast cancer

Published:2016-05-10 Issue:5 Volume:82 Page:1189-1212
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Steelman Linda S.¹,Martelli Alberto M.²,Cocco Lucio²,Libra Massimo³,Nicoletti Ferdinando³,Abrams Stephen L.¹,McCubrey James A.¹

Affiliation:

1. Department of Microbiology and Immunology; Brody School of Medicine at East Carolina University; Greenville NC USA

2. Dipartimento di Scienze Biomediche e Neuromotorie; Università di Bologna; Bologna Italy

3. Department of Biomedical and Biotechnological Sciences, Laboratory of Translational Oncology & Functional Genomics, Section of Pathology & Oncology; University of Catania; Catania Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12958/fullpdf

Reference95 articles.

1. American Cancer Society http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-046381.pdf

2. S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts;Bostner;Endocr Relat Cancer,2015

3. Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer;Chan;J Clin Oncol,2005

4. Evaluating temsirolimus activity in multiple tumors: a review of clinical trials;Dancey;Semin Oncol,2009

5. Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer;Buckner;Invest New Drugs,2010

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation;Translational Oncology;2024-10

2. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

3. Anticancer potential of delphinidin and its derivatives: therapeutic and mechanistic insights;Medicinal Chemistry Research;2024-08-14

4. Combined Effect of Sertraline and Capecitabine on Breast Cancer Cell Lines In Vitro and In Silico Evidence for Synergistic Interaction;Scientia Pharmaceutica;2024-07-15

5. A modular microfluidic platform to study how fluid shear stress alters estrogen receptor phenotype in ER+ breast cancer cells;Microsystems & Nanoengineering;2024-02-16